News

The Global Alliance issued its first call for proposals to conduct TB-related R&D fitting in the Alliance’s drug development strategy.

A new initiative to tackle tuberculosis (TB), the Global Alliance for TB Drug Development, was launched last week at the

A global alliance bringing together academia, public health agencies and the pharmaceutical industry has launched a fresh onslaught against the

La maladie fait deux millions de morts par an ASSURER la recherche et le développement de nouveaux traitements visant l’éradication

BANGKOK: A global effort to develop new anti-tuberculosis drugs by the year 2010, with an initial budget of $150 million,

BANGKOK, Oct. 12 (IPS) — More potent drugs and an easier-to-complete treatment for tuberculosis, a major killer in poor countries,

SCIENTISTS, governments and charitable groups around the world have linked up to tackle one of the deadliest infectious diseases –

In early October, an unusual alliance of 25 government and international health agencies, drug companies, and philanthropic foundations will meet